FDA Adverse Event Injury Summary report: N

REVANESSE VERSA+ 1.2 ML

MDR report key: 17007659 · Received May 25, 2023

Report

Report Number
3004423487-2023-00017
Event Type
Injury
Date Received
May 25, 2023
Date of Event
February 7, 2023
Report Date
May 25, 2023
Manufacturer
PROLLENIUM MEDICAL TECHNOLOGIES INC., AURORA, ON,
Product Code
LMH
UDI-DI
10669808001038
PMA / PMN Number
P160042 S004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
117

Narratives

Description of Event or Problem · 0

ON (B)(6) 2023, A PATIENT WAS INJECTED WITH 0.8 ML OF REVANESSE VERSA+ HA FILLER INTO THEIR LIPS. A TOPICAL ANESTHETIC WAS USED, OINTMENT LIDOCAINE 23%, TETRACAINE 7%, LIPS. PATIENT HAD A VIRAL INFECTION AND WAS IN BED FOR 2-3 DAYS. SHE NOTICED HER LIPS GOT SWOLLEN AND FORMED 2 LITTLE LUMPS. NO TREATMENT WAS GIVEN. SHE JUST MONITORED IT. IN A COUPLE OF DAYS WHEN SHE WAS FEELING BETTER, THE LIPS WERE NO LONGER SWOLLEN AND THE NODULES WENT AWAY. PROLLENIUM MEDICAL TECHNOLOGIES INC. WILL CONTINUE THE INVESTIGATION. INTERNAL REPORT NUMBER: (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1640117 REVANESSE VERSA+ 1.2 ML REVANESSE VERSA+ LMH PROLLENIUM MEDICAL TECHNOLOGIES INC., AURORA, ON, 40083 10669808001038

Patients

Seq Age Sex Outcome Treatment
1 27 YR Female